PMID- 30155908 OWN - NLM STAT- MEDLINE DCOM- 20190123 LR - 20190123 IS - 1600-0560 (Electronic) IS - 0303-6987 (Linking) VI - 45 IP - 12 DP - 2018 Dec TI - Review of the medical literature and assessment of current utilization patterns regarding the use of two common fluorescence in situ hybridization assays in the diagnosis of dermatofibrosarcoma protuberans and clear cell sarcoma. PG - 905-913 LID - 10.1111/cup.13345 [doi] AB - BACKGROUND: Dermatofibrosarcoma protuberans (DFSP) is a tumor of intermediate malignancy, which in selected circumstances can pose difficulty in diagnosis. Clear cell sarcoma (CCS) is a very rare aggressive soft tissue sarcoma that can be difficult to distinguish histologically from melanoma. METHODS: The current literature on t(17;22) COL1A1-PDGFB fluorescence in situ hybridization (FISH) assay in DFSP was reviewed. Also reviewed was the current literature on dual color break-apart EWSR1 FISH assay in CCS. Finally, the current utilization patterns of these tests was assessed in attendees of the American Society of Dermatopathology annual meeting (Chicago, 2016). RESULTS: The literature indicates that (17;22) COL1A1-PDGFB FISH assay has limited value for classic DFSP, where the diagnosis can be established by routine morphology and immunohistochemistry. Given the high specificity of the EWSR1 FISH assay and significant complexity in the diagnosis of CCS, this ancillary study is helpful in distinguishing CCS from melanoma. CONCLUSIONS: In attendees, t(17;22) COL1A1-PDGFB FISH testing for classic cases of DFSP is appropriately not being used by respondents. However, the literature sustains that it is useful in selected circumstances in which a definitive diagnosis is challenging. The majority of respondents are utilizing the EWSR1 FISH assay to distinguish CSS from melanoma as is supported by the literature. CI - (c) 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. FAU - Linos, Konstantinos AU - Linos K AUID- ORCID: 0000-0001-9462-652X AD - Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center and Geisel School of Medicine at Dartmouth Lebanon, Lebanon, New Hampshire. FAU - Kozel, Jessica A AU - Kozel JA AD - Midwest Pathology Associates, LLC, Overland Park, Kansas. FAU - Hurley, Maria Yadira AU - Hurley MY AUID- ORCID: 0000-0002-1162-7250 AD - Departments of Dermatology and Pathology, Saint Louis University School of Medicine, St. Louis, Missouri. FAU - Andea, Aleodor A AU - Andea AA AD - Departments of Dermatology and Pathology, University of Michigan Medical Center, Ann Arbor, Michigan. LA - eng PT - Journal Article PT - Review DEP - 20180927 PL - United States TA - J Cutan Pathol JT - Journal of cutaneous pathology JID - 0425124 SB - IM MH - Chromosomes, Human, Pair 17/*genetics MH - Chromosomes, Human, Pair 22/*genetics MH - *Dermatofibrosarcoma/diagnosis/genetics/pathology MH - Humans MH - In Situ Hybridization, Fluorescence/*methods MH - *Sarcoma, Clear Cell/diagnosis/genetics/pathology MH - *Skin Neoplasms/diagnosis/genetics/pathology MH - *Translocation, Genetic OTO - NOTNLM OT - EWSR1 OT - clear cell sarcoma OT - dermatofibrosarcoma protuberans OT - fluorescence in situ hybridization OT - t(17;22) COL1A1-PDGFB EDAT- 2018/08/30 06:00 MHDA- 2019/01/24 06:00 CRDT- 2018/08/30 06:00 PHST- 2017/10/09 00:00 [received] PHST- 2018/07/14 00:00 [revised] PHST- 2018/08/06 00:00 [accepted] PHST- 2018/08/30 06:00 [pubmed] PHST- 2019/01/24 06:00 [medline] PHST- 2018/08/30 06:00 [entrez] AID - 10.1111/cup.13345 [doi] PST - ppublish SO - J Cutan Pathol. 2018 Dec;45(12):905-913. doi: 10.1111/cup.13345. Epub 2018 Sep 27.